Cory D. Fulcher, M.D.

Gadsden NJ, Fulcher CD, Li D, Shrivastava N, Thomas C, Segall JE, Prystowsky MB, Schlecht NF, Gavathiotis E, Ow TJ. Palbociclib renders human papilloma virus-negative head and neck squamous cell carcinoma vulnerable to the senolytic agent navitoclax. Mol Cancer Res. 2021 Jan 25:molcanres.0915.2020.

Ow TJ, Thomas C, Fulcher CD, et al. Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma. Laryngoscope. 2020;10.1002/lary.28441.

Ow TJ, Fulcher CD, Thomas C, et al. Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1. Oncotarget. 2019;10(4):494-510.

Cory D. Fulcher; Carlos Thomas; Nicholas Gadsden; Daniel Li; Nick Ranellone; Michael Prystowsky; Thomas J. Ow. The CDK4/6 inhibitor palbociclib demonstrates efficacy alone and in combination with radiation in HPV-negative head and neck squamous cell carcinoma. Poster presented at the Combined Otolaryngology Spring Meeting for the American Head and Neck Society poster session. Austin, TX. May 2019. 

Fulcher CD, Haigentz M, Ow TJ. AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma Head & Neck. 2018; 40(4):676-686.

Cory D. Fulcher, Carlos Thomas, Michael B. Prystowsky, Richard V. Smith, Evripidis Gavathiotis, Chandan Guhan, Alan Alfieri, Thomas J. Belbin, Thomas Harris, Geoffrey Childs, Bradley A. Schiff, Nicolas Schlecht, Gregory Rosenblatt, Thomas J. Ow. Understanding and Targeting Mechanisms of Resistance to Apoptosis in Head and Neck Squamous Cell Carcinoma. Poster presented at the Combined Otolaryngology Spring Meeting for the American Head and Neck Society poster session. San Diego, CA. April 2017.

Awards

AHNS Best Resident Basic Science Research Paper COSM 2019

AHNS Poster of Distinction in Basic Science Research COSM 2017